Cite
MLA Citation
Steven O'Day et al.. “423 Safety and preliminary efficacy of intratumoral cavrotolimod (AST-008), a spherical nucleic acid TLR9 agonist, in combination with pembrolizumab in patients with advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A257–A258. http://access.bl.uk/ark:/81055/vdc_100144724074.0x000007